Methadone to Extended‑Release Oral Morphine Conversion Guidelines
Dose Calculation
- The total daily methadone dose is 40 mg (10 mg administered four times per day)【1】【2】.
- The established morphine‑to‑methadone potency ratio for converting from morphine to methadone is 2 : 1【1】【2】【3】【4】.
- Applying this ratio, 40 mg of methadone corresponds to an approximate 80 mg daily dose of extended‑release oral morphine【5】.
Pharmacologic Considerations
- Methadone exhibits incomplete cross‑tolerance with other opioids, necessitating dose reductions when switching【5】【6】.
- Its long and variable half‑life means substantial drug remains for several days after the last dose, complicating reverse conversions【5】.
Initial Dosing Recommendations (NCCN)
- Begin with 80 mg extended‑release morphine per day (40 mg every 12 h) as the standard 2 : 1 conversion, while anticipating frequent adjustments【5】【6】.
- If incomplete cross‑tolerance is a concern, reduce the calculated dose by 25–50 %, yielding a more conservative starting range of 40–60 mg extended‑release morphine daily【5】【6】.
Titration and Monitoring (NCCN & British Journal of Cancer)
- Provide immediate‑release morphine 10–15 mg every 2–4 h as needed for breakthrough pain during the first 3–7 days【7】.
- Monitor the total daily morphine consumption (regular plus breakthrough doses) to guide dose adjustments【7】.
- Adjust the extended‑release dose daily based on breakthrough medication use, with expected modifications every 1–2 days as methadone clears from the system【7】【5】.
- Anticipate that morphine requirements may increase over 3–7 days as methadone’s residual effects diminish【5】.
Safety Precautions (NCCN)
- Do not rely rigidly on standard equianalgesic tables when converting from methadone, as they tend to underestimate methadone’s potency in chronic use【5】.
- Avoid abrupt discontinuation of methadone without adequate morphine coverage to prevent withdrawal and uncontrolled pain【5】.
- Recognize that methadone clearance takes 1–2 days for substantial reduction and several days for complete elimination, requiring ongoing dose reassessment beyond the first 24 hours【5】.